Assignee
ISARNA THERAPEUTICS GMBH
DE·6 granted patents·2 pending applications·1 citations·filing 2014–2018
Top patents by PatentIndex Score
8 records- 0169US9688988B2Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic diseaseISARNA THERAPEUTICS GMBH·Filed 2014·Granted Jun 27, 2017·1 cites·11 claims
- 0255US9926563B2Modified TGF-beta oligonucleotidesISARNA THERAPEUTICS GMBH·Filed 2014·Granted Mar 27, 2018·0 cites·10 claims
- 0354US9840707B2Modified TGF-beta2 oligonucleotidesISARNA THERAPEUTICS GMBH·Filed 2014·Granted Dec 12, 2017·0 cites·6 claims
- 0454US2019144865A1Modified tgf-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic diseaseISARNA THERAPEUTICS GMBH·Filed 2018·Application pending·0 cites
- 0552US10125368B2Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic diseaseISARNA THERAPEUTICS GMBH·Filed 2017·Granted Nov 13, 2018·0 cites·9 claims
- 0649US10538768B2Modified TGF-beta oligonucleotidesISARNA THERAPEUTICS GMBH·Filed 2018·Granted Jan 21, 2020·0 cites·5 claims
- 0746US2018087055A1Modified tgf-beta2 oligonucleotidesISARNA THERAPEUTICS GMBH·Filed 2017·Application pending·0 cites
- 0837US11207341B2TGF-beta oligonucleotide for use in treatment of ophthalmic diseasesISARNA THERAPEUTICS GMBH·Filed 2017·Granted Dec 28, 2021·0 cites·18 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →